The study demonstrates a method to identify and characterize foot-and-mouth disease virus gene products using antisera raised against bacterially synthesized fusion proteins.
Supports FMDV protein mapping via bacterial antisera; hypothesis-generating and leaves open applications in diagnostics or vaccines.
Defined segments of the cloned foot-and-mouth disease virus genome corresponding to all parts of the coding region were expressed in Escherichia coli as fusions to the N-terminal part of the MS2-polymerase gene under the control of the inducible lambda PL promoter. All constructs yielded large amounts of proteins, which were purified and used to raise sequence-specific antisera in rabbits. These antisera were used to identify the corresponding viral gene products in 35S-labeled extracts from foot-and-mouth disease virus gene products in the nucleotide sequence, to identify precursor-product relationships, and to detect several foot-and-mouth disease virus gene products not previously identified in vivo or in vitro.
No takes yet. Share an insight, caveat, or question.
Strebel et al. (1986) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: